CD274 and prostate carcinoma: This immunologically “deserted” environment is maintained by several convergent mechanisms, including the upregulation of co-inhibitory molecules, whereby prostate cancer cells express PD-L1 and other ligands that interact with T-cell checkpoints such as PD-1 and CTLA-4, leading to T-cell exhaustion [28,29].